Cargando…

Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients

BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhuang, Yi-Han, Chou, Yu-Ching, Lin, Yu-Chun, Hu, Je-Ming, Pu, Ta-Wei, Chen, Chao-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107215/
https://www.ncbi.nlm.nih.gov/pubmed/37077516
http://dx.doi.org/10.3748/wjg.v29.i11.1735
_version_ 1785026558780506112
author Jhuang, Yi-Han
Chou, Yu-Ching
Lin, Yu-Chun
Hu, Je-Ming
Pu, Ta-Wei
Chen, Chao-Yang
author_facet Jhuang, Yi-Han
Chou, Yu-Ching
Lin, Yu-Chun
Hu, Je-Ming
Pu, Ta-Wei
Chen, Chao-Yang
author_sort Jhuang, Yi-Han
collection PubMed
description BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon cancer. METHODS: This was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival. RESULTS: There were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010). CONCLUSION: Patients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome.
format Online
Article
Text
id pubmed-10107215
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-101072152023-04-18 Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients Jhuang, Yi-Han Chou, Yu-Ching Lin, Yu-Chun Hu, Je-Ming Pu, Ta-Wei Chen, Chao-Yang World J Gastroenterol Retrospective Cohort Study BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon cancer. METHODS: This was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival. RESULTS: There were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010). CONCLUSION: Patients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome. Baishideng Publishing Group Inc 2023-03-21 2023-03-21 /pmc/articles/PMC10107215/ /pubmed/37077516 http://dx.doi.org/10.3748/wjg.v29.i11.1735 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Cohort Study
Jhuang, Yi-Han
Chou, Yu-Ching
Lin, Yu-Chun
Hu, Je-Ming
Pu, Ta-Wei
Chen, Chao-Yang
Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title_full Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title_fullStr Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title_full_unstemmed Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title_short Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
title_sort risk factors predict microscopic extranodal tumor deposits in advanced stage iii colon cancer patients
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107215/
https://www.ncbi.nlm.nih.gov/pubmed/37077516
http://dx.doi.org/10.3748/wjg.v29.i11.1735
work_keys_str_mv AT jhuangyihan riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients
AT chouyuching riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients
AT linyuchun riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients
AT hujeming riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients
AT putawei riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients
AT chenchaoyang riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients